The Trump administration’s plan to address the opioid crisis focuses on preventing overdose deaths, but neglects the ...

How could a non-opioid painkiller improve the lives of people with chronic pain? What makes a non-opioid painkiller safer ...

The availability of suzetrigine may represent a critical step in addressing the nation’s pain management crisis. While ...

Ben Hargreaves finds that a new line of attack could be the development of more effective non-opioid painkillers, with one potential therapy moving closer to approval. The opioid epidemic in the ...

This crisis doesn’t discriminate. It affects working parents, young people and seniors — many of whom end up dependent ...

New research highlights how the brain’s own chemistry can suppress pain, explaining why severely injured individuals, like ...

The hope is that a new generation of non-opioid analgesics will become available to treat both acute and chronic pain and have a reduced risk of addiction. In 2023, more than 100,000 lives were ...

Pacira Biosciences has authorized a share buyback program of up to $300 million. The developer of non-opioid pain relievers said Thursday the repurchase program replaces a previous $150 million ...